Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line.
about
PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma.The Addition of Target Therapy to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review.Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up.
P2860
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@en
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@nl
type
label
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@en
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@nl
prefLabel
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@en
Gefitinib enhances the effects ...... a colorectal cancer cell line.
@nl
P2093
P2860
P50
P1476
Gefitinib enhances the effects ...... a colorectal cancer cell line
@en
P2093
Cynthia Aristei
Debora Cecchini
Fabio Maria Vecchio
Franca Falzetti
Isabella Palumbo
Monica Calzuola
Simonetta Piattoni
P2860
P2888
P356
10.1007/S00384-013-1754-1
P577
2013-08-06T00:00:00Z